|
Tiempo real estimado
Otros sitios de cotización
|
Variación 5 días | Varia. 1 de enero. | ||
| 13.843,00 GBX | +0,56 % |
|
+3,92 % | +0,33 % |
| 12:14 | La inmunoterapia de AstraZeneca contra el cáncer de estómago recibe luz verde para su uso en el NHS | AN |
| 11:44 | ASTRAZENECA : recomendación de compra de JP Morgan | ZD |
Principales competidores
Añadir a una lista 0 seleccionado | Ratio PER (Y) | Ratio PBR (Y) | PEG (Y) | VE / Ventas (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Rentabilidad (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 23.43x | 5.43x | 1.09x | 4.86x | 13.81x | 14.51x | 1,79 % | 289 mil M | |
| 29.8x | 17.79x | 0.61x | 10.81x | 22.32x | 22.76x | 0,67 % | 906 mil M | |
| 24.63x | 6.2x | -1.62x | 5.68x | 15.43x | 17.06x | 2,32 % | 555 mil M | |
| 25.42x | -2779.26x | 0.1x | 6.28x | 12.82x | 13.2x | 3,29 % | 368 mil M | |
| 16.92x | 6.21x | 0.94x | 4.24x | 10.45x | 11.85x | 3,13 % | 326 mil M | |
| 20.6x | 6.19x | 41.04x | 5.55x | 13.49x | 14.7x | 3,01 % | 285 mil M | |
| 50.61x | 5.76x | -0.73x | 4.74x | 19.25x | 26.75x | 2,94 % | 280 mil M | |
| 13.54x | 5.87x | -3.32x | 4.96x | 10.13x | 11.92x | 3,73 % | 208 mil M | |
| 21.88x | 16.31x | 2.71x | 5.9x | 10.3x | 13.49x | 3 % | 182 mil M | |
| -48.08x | 8.3x | 0.34x | 5.74x | 32.75x | 65.4x | 2,44 % | 165 mil M | |
| 12.14x | 1.69x | 0.21x | 3.18x | 7.69x | 9.02x | 6,75 % | 148 mil M | |
| 11.05x | 4.89x | 0.23x | 3.04x | 8.13x | 8.84x | 4,46 % | 115 mil M | |
| 25.95x | 5.03x | 1.86x | 7.72x | 17.41x | 18.13x | -.--% | 115 mil M | |
| 10.63x | 1.17x | 1.54x | 2.13x | 6.9x | 7.61x | 5,9 % | 102 mil M | |
| 11.76x | 4.08x | 0.86x | 2.6x | 7.62x | 8.57x | 3,71 % | 102 mil M | |
| 25.16x | 5.72x | 1.43x | 8.59x | 16.16x | 16.95x | 1,75 % | 81,37 mil M | |
| 39.76x | 5.37x | 2.09x | 9.02x | 29.91x | 30.99x | 0,49 % | 54,61 mil M | |
| 46.2x | 1.15x | 0.72x | 2.68x | 9.89x | 28.04x | 3,85 % | 51,96 mil M | |
| 16.32x | 1.32x | -0.1x | 1.52x | 7.26x | 11.96x | 0,58 % | 43,68 mil M | |
| 31.09x | 4.35x | -8.57x | 3.23x | 11.07x | 13.11x | -.--% | 42,21 mil M | |
| Promedio | 20,44x | -133,32x | 2,07x | 5,12x | 14,14x | 18,24x | 2,69 % | 220,98 mil M | |
| Media ponderada por Capi. | 22,21x | -223,72x | 2,73x | 6,27x | 15,69x | 18,58x | 2,47 % |
- Bolsa de valores
- Acciones
- Acción AZN
- Sector AstraZeneca PLC
- Valoraciones sectoriales
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
Seguir con la edición actual